CVS Health Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One decreased by 13.0% to $838.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $816.00M to $838.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate greater near-term liquidity, allowing the company to reinvest or fund operations without selling assets.
This metric tracks the fair value of debt securities in the available-for-sale portfolio that are scheduled to mature wi...
Standard maturity profile disclosure for utilities with structured investment portfolios.
other_available_for_sale_securities_debt_maturities_with_de2040| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.18B | $1.07B | $1.24B | $1.22B | $1.29B | $1.40B | $1.29B | $1.25B | $1.25B | $1.35B | $816.00M | $1.19B | $963.00M | $838.00M |
| QoQ Change | — | -9.5% | +15.3% | -1.1% | +5.5% | +8.3% | -7.7% | -2.6% | -0.7% | +8.4% | -39.5% | +45.7% | -19.0% | -13.0% |
| YoY Change | — | — | — | +3.2% | +20.3% | +13.0% | +5.5% | -2.6% | -10.8% | +4.7% | -34.9% | -4.5% | -28.6% | +2.7% |